1 Department of anaesthesiology and surgical intensive care, Hôtel-Dieu, University Hospital of Nantes, 44093 Nantes, France; School of medicine, UPRES EA3826, thérapeutiques cliniques et expérimentales des infections, IRS2 Nantes Biotech, 44000 Nantes, France.
2 Department of anaesthesiology and surgical intensive care, Hôtel-Dieu, University Hospital of Nantes, 44093 Nantes, France; School of medicine, UPRES EA3826, thérapeutiques cliniques et expérimentales des infections, IRS2 Nantes Biotech, 44000 Nantes, France. Electronic address: karim.asehnoune@chu-nantes.fr.